Development of an Integrated mHealth App-Based Intervention to Support Smoking Cessation in People Living with HIV

开发基于移动医疗应用程序的综合干预措施以支持艾滋病毒感染者戒烟

基本信息

  • 批准号:
    10265170
  • 负责人:
  • 金额:
    $ 25.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT The advent of highly active antiretroviral therapy (HAART) has greatly reduced mortality in persons living with HIV (PLWH), to the point where now lifestyle-related factors pose greater threat to long-term survival than HIV, chief among them smoking. Although interest in quitting smoking is high amongst PLWH, the prevalence of smoking among PLWH remains more than twice as high as that in the general population. Encouragingly, there have been successes in leveraging HIV primary care settings to engage PLWH smokers in smoking cessation efforts. Scaling up and expanding on this success has been difficult, however, as past evidence has indicated that interventions with more sessions produced stronger effects. High intensity face-to-face interventions are not readily scalable. Mobile health (mHealth) approaches, however, can provide continuous and as-needed support over longer periods of time, reducing the need for in-person treatment while providing prolonged support. To this end, and building on our previous work, we propose to develop an mHealth intervention that integrates (1) the “Smiling instead of Smoking” (SiS) app, a conceptually-grounded, iteratively developed smoking cessation smartphone app (M-PI Hoeppner), (2) a successful face-to- face smoking cessation treatment for SLH, called QUIT (M-PI O'Cleirigh), and (3) Life Steps, our efficacious brief intervention to promote adaptive engagement in HIV care. This integrated treatment will be informed and specified through the completion of the treatment development aims. We anticipate that it will combine initial face-to-face, SLH-focused treatment with SLH-adapted, real-time, temporally tailored smartphone app support over 8 weeks. Aim 1 is to build the integrated mHealth app intervention (SiS-H) based on feedback derived in user-centered design research with smokers living with HIV (SLH), consultation with HIV smoking cessation scientists and clinicians, and collaboration with our software development partner. Aim 2 is to conduct a proof-of-concept randomized controlled trial to test the feasibility, acceptability, and preliminary efficacy of SiS-H, while tracking HIV-specific outcomes. The app to be adapted is Version 3 of the SiS app, which is based on social cognitive theory, and implements clinical practice guidelines within a positive psychology framework. The proposed integrated treatment will emphasize protecting the experience of positive emotions among SLH as they navigate quitting smoking, and support increased self-efficacy through the complementing skills-based training of the QUIT and Life Steps components. The proposed project advances the critically important public health goal of making smoking cessation support more readily available to PLWH smokers. More pragmatically, data from this project could inform the design of a larger R01-funded RCT and the necessary regulatory strategy to advance towards approval of SiS-H as a prescription treatment that could well be sustainable in HIV primary care and other community health clinical settings.
项目摘要 /摘要 高度活跃的抗逆转录病毒疗法(HAART)的冒险经历大大降低 艾滋病毒(PLWH),以至于现在与生活方式相关的因素对长期生存构成比艾滋病毒更大的威胁 他们中的主要吸烟。虽然在静静的吸烟中很有趣,但普遍存在 PLWH之间的吸烟仍然是普通人群的两倍以上。令人鼓舞的是, 已经成功利用艾滋病毒初级保健环境让PLWH吸烟者吸烟 停止工作。但是,由于过去的证据已经有了扩大和扩展,因此很难 表明更多会议的干预措施产生了更强的影响。高强度面对面 干预措施不容易扩展。但是,移动健康(MHealth)方法可以提供连续的 并需要在更长的时间内支持,从而减少了对面对面治疗的需求 长期支持。为此,我们在以前的工作中建立了基础,我们建议开发MHealth 整合(1)“微笑而不是吸烟”(SIS)应用程序的干预措施,这是一个概念上的, 迭代开发的戒烟智能手机应用程序(M-PI Hoeppner),(2)成功面对面 面对SLH的戒烟治疗,称为戒烟(M-Pi O'Clairigh),以及(3)生命步骤,我们 简单的简短干预措施以促进适应性参与艾滋病毒护理。这种综合治疗将 通过完成治疗开发的目的来了解和指定。我们预计会 将初始面对面的,以SLH为中心的治疗与SLH适应的实时,临时量身定制 智能手机应用程序支持8周。目标1是建立集成的MHealth应用程序干预(SIS-H) 基于以用户为中心的设计研究得出的反馈,与艾滋病毒(SLH)的吸烟者(SLH)咨询 与艾滋病毒戒烟科学家和临床医生一起,并与我们的软件开发伙伴合作。 目标2是进行概念验证随机对照试验,以测试可行性,可接受性和 SIS-H的初步效率,同时跟踪HIV特异性结果。要改编的应用程序是 基于社会认知理论的SIS应用程序,并将临床实践指南实现 心理学框架。拟议的综合治疗将强调保护 SLH在吸烟中引起积极情绪,并通过 基于技能的戒烟和生命步骤组件的补充培训。拟议的项目 促进使吸烟支持更容易获得的至关重要的公共卫生目标 吸烟者。更务实地,该项目的数据可以为较大的R01资助的设计提供信息 RCT和促进SIS-H批准作为处方处理的必要监管策略 这在HIV初级保健和其他社区健康临床环境中很可能是可持续的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bettina B. Hoeppner其他文献

Use of text messages to increase positive affect and promote physical activity in patients with heart disease
使用短信增加心脏病患者的积极影响并促进身体活动
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Sean R. Legler;C. Celano;E. Beale;Bettina B. Hoeppner;Jeff C. Huffman
  • 通讯作者:
    Jeff C. Huffman
Manic symptoms in youth with bipolar disorder: Factor analysis by age of symptom onset and current age
  • DOI:
    10.1016/j.jad.2012.06.024
  • 发表时间:
    2013-03-05
  • 期刊:
  • 影响因子:
  • 作者:
    David R. Topor;Lance Swenson;Jeffrey I. Hunt;Boris Birmaher;Michael Strober;Shirley Yen;Bettina B. Hoeppner;Brady G. Case;Heather Hower;Lauren M. Weinstock;Neal Ryan;Benjamin Goldstein;Tina Goldstein;Mary Kay Gill;David Axelson;Martin Keller
  • 通讯作者:
    Martin Keller

Bettina B. Hoeppner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bettina B. Hoeppner', 18)}}的其他基金

Analysis Core (Anc)
分析核心(Anc)
  • 批准号:
    10729791
  • 财政年份:
    2023
  • 资助金额:
    $ 25.2万
  • 项目类别:
Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers
随机临床试验,测试智能手机应用程序对非日常吸烟者戒烟的功效
  • 批准号:
    10715401
  • 财政年份:
    2023
  • 资助金额:
    $ 25.2万
  • 项目类别:
Leveraging community-based participatory research and infoveillance to advance the science on recovery community centers serving Black communities
利用基于社区的参与性研究和信息监视来推进为黑人社区服务的康复社区中心的科学
  • 批准号:
    10661973
  • 财政年份:
    2023
  • 资助金额:
    $ 25.2万
  • 项目类别:
Planning grant for a multi-site trial to examine the effectiveness of recovery community centers serving Black communities to support persons using medications for opioid use disorder
为多地点试验规划拨款,以检查为黑人社区服务的康复社区中心支持使用阿片类药物使用障碍药物的人的有效性
  • 批准号:
    10588672
  • 财政年份:
    2022
  • 资助金额:
    $ 25.2万
  • 项目类别:
Development of an Integrated mHealth App-Based Intervention to Support Smoking Cessation in People Living with HIV
开发基于移动医疗应用程序的综合干预措施以支持艾滋病毒感染者戒烟
  • 批准号:
    10408833
  • 财政年份:
    2021
  • 资助金额:
    $ 25.2万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10393670
  • 财政年份:
    2020
  • 资助金额:
    $ 25.2万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10213688
  • 财政年份:
    2020
  • 资助金额:
    $ 25.2万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10754705
  • 财政年份:
    2020
  • 资助金额:
    $ 25.2万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10629183
  • 财政年份:
    2020
  • 资助金额:
    $ 25.2万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder: Administrative Supplement
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人:行政补充
  • 批准号:
    10317332
  • 财政年份:
    2020
  • 资助金额:
    $ 25.2万
  • 项目类别:

相似海外基金

Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
  • 批准号:
    10706874
  • 财政年份:
    2023
  • 资助金额:
    $ 25.2万
  • 项目类别:
Women focused Encounters for Resilience, Independence, Strength and Eudaimonia (WE RISE)
以女性为中心的韧性、独立、力量和幸福的邂逅 (WE RISE)
  • 批准号:
    10744678
  • 财政年份:
    2023
  • 资助金额:
    $ 25.2万
  • 项目类别:
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
用于治疗 HIV 诊所兴奋剂使用的 reSET:护理优化支持治疗依从性 (COSTA)
  • 批准号:
    10553554
  • 财政年份:
    2022
  • 资助金额:
    $ 25.2万
  • 项目类别:
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
Quit4Life:针对乌干达和赞比亚艾滋病毒感染者调整和评估基于电话的戒烟计划
  • 批准号:
    10269613
  • 财政年份:
    2021
  • 资助金额:
    $ 25.2万
  • 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
  • 批准号:
    10441828
  • 财政年份:
    2021
  • 资助金额:
    $ 25.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了